-
Mashup Score: 3
Pulsed field ablation (PFA) is emerging as an efficient, effective and safe energy source to achieve pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF).1,2 One of the most appealing aspects of PFA compared to conventional thermal ablation sources is the differential tissue sensitivity with reported tissue-specific ablation thresholds.3,4 Pre-clinical studies with different PFA platforms have suggested that selective myocardial ablation can be achieved, with sparing of adjacent non-myocardial tissue such as nerves, vascular structures and esophageal tissue.
Source: www.heartrhythmjournal.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 12Predictors of Non-Pulmonary Vein Triggers for Atrial Fibrillation: A Clinical Risk Score - 10 month(s) ago
Targeting non-pulmonary vein triggers (NPVTs) after pulmonary vein isolation may reduce atrial fibrillation (AF) recurrence. Isoproterenol infusion and cardioversion of spontaneous or induced AF can provoke NPVTs but typically require vasopressor support and increased procedure time.
Source: www.heartrhythmjournal.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 9CardiQ Quality Improvement Portal - 1 year(s) ago
The CardiQ quality improvement portal provides resources to help organizations provide care to Atrial Fibrillation patients
Source: cardiq.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 10
As the most common cause of syncope, vasovagal syncope (VVS) is the result of cerebral hypoperfusion caused by sudden-onset bradycardia and mediated by parasympathetic overdrive.1 VVS is generally categorized into three types: cardioinhibitory, vasodepressive and mixed type. Patients with recurrent syncope are first treated with conservative measures such as fluid and salt intake, trigger avoidance, and physical counter-pressure maneuvers. Similar to VVS, parasympathetic overdrive, affecting the sinus node (SAN) and atrioventricular node (AVN), may cause symptomatic sinus nodal dysfunction (SND) and atrioventricular block (AVB).
Source: www.heartrhythmjournal.comCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 2Pulsed-field ablation vs radiofrequency ablation for ventricular tachycardia: First in-human case of histologic lesion analysis - 1 year(s) ago
Ventricular tachycardia (VT) is a potentially life-threatening complication in postacute myocardial infarction (AMI) patients that can appear months or years after the index event.1 Although advancements in catheter ablation techniques have been made in recent years, the outcomes still are suboptimal, with a high long-term rate of relapse.1 Radiofrequency ablation (RFA) currently is the main energy used for these procedures. However, some histologic studies showed that the ability of RFA to form deep lesions is compromised in areas of scar tissue.
Source: www.heartrhythmjournal.comCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 2
The issue of the risk of direct current shock in patients with CIEDs is a subject that has been of concern for many years.1–3 As the authors have pointed out, there are case reports of damage to pulse generators and the lead-tissue interface.4 This informed the writing group of the Heart Rhythm Society perioperative management document 10 years ago to recommend that patients who have cardioversion have their CIEDs interrogated before leaving a monitored environment. However, in practice, this does not seem to have occurred very often.
Source: www.heartrhythmjournal.comCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 2Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation | NEJM - 1 year(s) ago
Original Article from The New England Journal of Medicine — Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
Source: www.nejm.orgCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 1EP News: Allied Professionals - 1 year(s) ago
Using data from 5 landmark primary prevention (PP) implantable cardioverter-defibrillator (ICD) trials, Younis et al (Circulation 2023;148:241, PMID 37459413) sought to assess whether there was any racial difference in the risk of ventricular arrhythmias (VAs) and atrial arrhythmias (AAs). All patients self-identified as white or black. All 5 trials defined ischemic cardiomyopathy (ICM) as documented previous myocardial infarction or coronary intervention such as bypass grafting or angioplasty. Nonischemic cardiomyopathy (NICM) was defined as any abnormality in the myocardium capable of producing heart failure (HF) but does not meet criteria for ICM.
Source: www.heartrhythmjournal.comCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 2How Much AF Warrants Anticoagulation? - 1 year(s) ago
Electrophysiologist John Mandrola reviews the NOAH-AFNET 6 trial presented at the European Society of Cardiology Congress 2023, which compared edoxaban vs placebo in patients with atrial high-rate episodes.
Source: www.medscape.comCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 2Heart Rhythm Society Education Council Update - 1 year(s) ago
A major focus of the Heart Rhythm Society (HRS) has been education of physicians, scientists, allied health professionals, patients, and other stakeholders. Numerous committees and initiatives of the HRS have contributed to the advancement of the education mission. This is epitomized by the HRS annual meeting, the preeminent “touch point” for heart rhythm specialists. The HRS Education Council was formed in 2021 by the HRS Board of Trustees to address the many thus far disconnected educational offerings of HRS committees and to identify opportunities for strategic alignment.
Source: www.heartrhythmjournal.comCategories: Cardiologists1, Latest HeadlinesTweet
RT @hrs_journal: Managing Vagal Responses Induced By Pulsed Field Ablation: Go Right First? https://t.co/akOqMWJal2